Our technology is created with passion.
Apeiron was founded in 2009 to bring Nobel prize winning olefin methatesis technology to the chemical industry and demonstrate its potential as a powerful yet cost-efficient and sustainable alternative to the well-established catalytic transformations.
We thrive on helping our partners elevate their chemical processes by developing robust solutions and providing end-to-end olefin metathesis services.
The Catalyst Review awarded Apeiron's R&D efforts
Rafał Gawin as new Chief Scientific Officer
Let's meet at CPHI Barcelona 2023